|
Q3 2021
|
6 |
14,090 |
LYRA, XFOR, LIFE, DARE
|
13F-HR
|
11/12/2021 |
000095012321014983 |
|
Q2 2021
|
7 |
62,416 |
FATE, LYRA, XFOR, LIFE
|
13F-HR
|
8/12/2021 |
000095012321010562 |
|
Q1 2021
|
8 |
77,123 |
FATE, LYRA, SELB, XFOR
|
13F-HR
|
5/12/2021 |
000095012321006061 |
|
Q4 2020
|
8 |
76,627 |
FATE, LYRA, SELB, XFOR
|
13F-HR
|
2/12/2021 |
000095012321002026 |
|
Q3 2020
|
9 |
60,651 |
FATE, LYRA, SELB, STIM
|
13F-HR
|
11/12/2020 |
000095012320011530 |
|
Q2 2020
|
10 |
128,486 |
Phreesia, Inc., FATE, LYRA, SELB
|
13F-HR
|
8/12/2020 |
000095012320008364 |
|
Q1 2020
|
10 |
110,489 |
Phreesia, Inc., FATE, SELB, KALA
|
13F-HR
|
5/14/2020 |
000095012320004952 |
|
Q4 2019
|
11 |
137,489 |
Phreesia, Inc., FATE, CDLX, SELB
|
13F-HR
|
2/12/2020 |
000095012320001644 |
|
Q3 2019
|
11 |
175,992 |
Phreesia, Inc., CDLX, FATE, STIM
|
13F-HR
|
11/13/2019 |
000095012319010847 |
|
Q2 2019
|
12 |
127,297 |
CDLX, FATE, KALA, STIM
|
13F-HR
|
8/12/2019 |
000095012319007582 |
|
Q1 2019
|
12 |
118,166 |
CDLX, FATE, KALA, STIM
|
RESTATEMENT
|
6/28/2019 |
000095012319006150 |
|
Q4 2018
|
12 |
93,682 |
CDLX, FATE, STIM, KALA
|
13F-HR
|
2/14/2019 |
000095012319001778 |
|
Q3 2018
|
12 |
199,740 |
CDLX, FATE, STIM, SELB
|
13F-HR
|
11/13/2018 |
000095012318011346 |
|
Q2 2018
|
12 |
183,498 |
CDLX, FATE, KALA, STIM
|
13F-HR
|
8/14/2018 |
000095012318008435 |
|
Q1 2018
|
11 |
175,413 |
XFOR, CDLX, KALA, FATE
|
13F-HR
|
5/4/2018 |
000095012318004197 |
|
Q4 2017
|
10 |
113,413 |
KALA, XFOR, SELB, FATE
|
RESTATEMENT
|
5/3/2018 |
000095012318004121 |
|
Q3 2017
|
9 |
116,325 |
KALA, SELB, FATE, LIFE
|
13F-HR
|
11/14/2017 |
000095012317010939 |
|
Q2 2017
|
8 |
96,643 |
SELB, DARE, GNCA, PULM
|
13F-HR
|
8/14/2017 |
000095012317008010 |
|
Q1 2017
|
9 |
93,414 |
SELB, PULM, GNCA, FATE
|
13F-HR
|
5/15/2017 |
000095012317005343 |
|
Q4 2016
|
9 |
84,247 |
SELB, TRVN, T2 Biosystems, Inc., GNCA
|
13F-HR
|
2/14/2017 |
000095012317001896 |
|
Q3 2016
|
9 |
94,723 |
SELB, TRVN, T2 Biosystems, Inc., GNCA
|
13F-HR
|
11/9/2016 |
000095012316021526 |
|
Q2 2016
|
10 |
93,152 |
SELB, T2 Biosystems, Inc., TRVN, GNCA
|
13F-HR
|
7/28/2016 |
000095012316018588 |
|
Q1 2016
|
9 |
104,670 |
TRVN, T2 Biosystems, Inc., GNCA, OCUL
|
13F-HR
|
5/13/2016 |
000095012316017102 |
|
Q4 2015
|
9 |
127,294 |
TRVN, T2 Biosystems, Inc., LIFE, PULM
|
13F-HR
|
2/16/2016 |
000095012316015144 |
|
Q3 2015
|
9 |
146,773 |
TRVN, LIFE, PULM, T2 Biosystems, Inc.
|
13F-HR
|
11/10/2015 |
000095012315011169 |
|
Q2 2015
|
9 |
224,225 |
T2 Biosystems, Inc., PULM, LIFE, GNCA
|
13F-HR
|
8/11/2015 |
000095012315008468 |
|
Q1 2015
|
7 |
223,829 |
OCUL, T2 Biosystems, Inc., DARE, TRVN
|
13F-HR
|
5/14/2015 |
000095012315006046 |
|
Q4 2014
|
6 |
126,401 |
T2 Biosystems, Inc., TRVN, DARE, GNCA
|
RESTATEMENT
|
5/14/2015 |
000095012315006043 |
|
Q3 2014
|
6 |
129,578 |
T2 Biosystems, Inc., TRVN, GNCA, BINDQ
|
RESTATEMENT
|
5/14/2015 |
000095012315006049 |
|
Q2 2014
|
5 |
122,723 |
GNCA, BINDQ, TRVN, DARE
|
13F-HR
|
8/11/2014 |
000095012314008258 |
|
Q1 2014
|
6 |
120,388 |
GNCA, TRVN, BINDQ, FATE
|
13F-HR
|
5/1/2014 |
000095012314004759 |